6-溴-2-甲基苯酚 | 13319-71-6

• 物质功能分类: 化学试剂 - 有机试剂 - 酚类
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 6-溴-2-甲基苯酚
• 中文别名: 6-溴邻甲酚；2-溴-6-甲基苯酚
• 英文名称: 2-bromo-6-methylphenol
• 英文别名: 6-methyl-2-bromophenol；6-bromo-o-cresol
• CAS: 13319-71-6
• 化学式: C₇H₇BrO
• 分子量: 187.036
• InChiKey: YXZPTVOCJLCMRO-UHFFFAOYSA-N

物化性质

• 熔点：
  16 °C
• 沸点：
  208 °C
• 密度：
  1.51

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319
• 储存条件：
  | 室温 |

SDS

6-Bromo-o-cresol Revision number: 1
SAFETY DATA SHEET

---

Section 1. BASE INFORMATION
Product name: 6-Bromo-o-cresol

Revision number: 1

---

Section 2. HAZARDS IDENTIFICATION
Classification of the GHS
PHYSICAL HAZARDS
Flammable liquids Category 4
HEALTH HAZARDS
Skin corrosion/irritation Category 2
Category 2A
Serious eye damage/eye irritation
ENVIRONMENTAL HAZARDS Not classified
GHS label elements
Pictograms or hazard symbols
Signal word Warning
Hazard statement Combustible liquid
Causes skin irritation
Causes serious eye irritation
Precautionary statements
[Prevention] Keep away from flames and hot surfaces.
Wash hands thoroughly after handling.
Wear protective gloves and eye/face protection.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses,
[Response]
if present and easy to do. Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Gently wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Take off contaminated clothing and wash before reuse.
Store in a well-ventilated place. Keep cool.
[Storage]
[Disposal] Dispose of contents/container through a waste management company authorized by
the local government

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Component(s): 6-Bromo-o-cresol
>94.0%(GC)
Percent:
CAS Number: 13319-71-6
2-Bromo-6-methylphenol
Synonyms:
Chemical Formula: C7H7BrO
6-Bromo-o-cresol

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Gently wash with plenty of
soap and water. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
Protection of first-aiders: A rescuer should wear personal protective equipment, such as rubber gloves and air-
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Extinguishing media not to Solid streams of water
be used:
Specific hazards: Take care as it may decompose upon combustion or in high temperatures to
generate poisonous fume.
Specific methods: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
When extinguishing fire, be sure to wear personal protective equipment.
Special protective
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Use personal protective equipment. Keep people away from and upwind of spill/leak.
Personal precautions,
protective equipment and Ensure adequate ventilation. Entry to non-involved personnel should be controlled
emergency procedures: around the leakage area by roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Absorb spilled material in a suitable absorbent (e.g. rag, dry sand, earth, saw-dust).
containment and cleaning In case of large amount of spillage, contain a spill by bunding. Adhered or collected
up: material should be promptly disposed of, in accordance with appropriate laws and
regulations.
Prevention of secondary Remove all sources of ignition. Fire-extinguishing devices should be prepared in
hazards: case of a fire. Use spark-proof tools and explosion-proof equipment.

---

Section 7. HANDLING AND STORAGE
Handling
Technical measures: Handling is performed in a well ventilated place. Wear suitable protective equipment.
Prevent generation of vapor or mist. Keep away from flames and hot surfaces. Take
measures to prevent the build up of electrostatic charge. Use explosion-proof
equipment. Wash hands and face thoroughly after handling.
Use a closed system, ventilation.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Storage
Storage conditions: Keep container tightly closed. Store in a cool, dark and well-ventilated place.
Store away from incompatible materials such as oxidizing agents.
Packaging material: Law is followed.

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Install a closed system or local exhaust as possible so that workers should not be
Engineering controls:
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Vapor respirator. Follow local and national regulations.
6-Bromo-o-cresol

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Hand protection: Protective gloves.
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Liquid
clear
Form:
Color: Very pale yellow - Yellow
Odor: No data available
pH: No data available
Melting point/freezing point:16 °C
Boiling Point/Range: 208 °C
Flash Point: No data available
Explosive limits
No data available
Lower:
Upper: No data available
Density: 1.51
Solubility: No data available

---

Section 10. STABILITY AND REACTIVITY
Stability: Stable under proper conditions.
Reactivity: No special reactivity has been reported.
Incompartible materials: oxidizing agents
Hazardous Decomposition Carbon monoxide, Carbon dioxide, Hydrogen bromide
Products:

---

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
No data available
IARC =
NTP = No data available
No data available
Reproductive toxicity:

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobillity in soil
log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to burn in a chemical
incinerator equipped with an afterburner and scrubber system. Observe all federal, state and local regulations when
disposing of the substance.
6-Bromo-o-cresol

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not Listed

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26,
2002): Safe use and production, the storage of a dangerous chemical, transport, loading and unloading were
prescribed.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-溴-2-甲基苯酚 在 双(三环己基膦)钯 、 potassium carbonate 、 cesium pivalate 作用下， 以 丙酮 、 甲苯 为溶剂， 反应 16.0h， 生成 2,3-二氢苯并呋喃
  参考文献：
  名称：

  由1,4-钯位移实现的两个C（sp3）-H键之间的氧化还原-中性偶联，用于合成杂环。

  摘要：

  通过从三取代的芳基溴化物进行的1,4-Pd转移，可以使两个C（sp3）-H键形成一个C（sp3）-C（sp3）键进行分子内偶联。与大多数C（sp3）-C（sp3）交叉脱氢偶联相反，该反应在氧化还原中性条件下进行，其中C-Br键充当内部氧化剂。此外，它允许两个中等酸性的伯或仲CH键之间的偶联，其在一侧与氧或氮原子相邻，而在另一侧为苄基或与羰基相邻。从易于获得的邻溴苯酚和苯胺前体中获得了各种有价值的稠合杂环。第二个CH键裂解成功地被羰基插入取代，以生成其他类型的C（sp3）-C（sp3）键。

  DOI：

  10.1002/anie.201908460
• 作为产物：
  描述：

  邻甲酚 在 N-溴代丁二酰亚胺(NBS) 、 二异丙胺 作用下， 生成 6-溴-2-甲基苯酚
  参考文献：
  名称：

  使用基于Taddol的手性膦-亚磷酸酯配体的不对称加氢甲酰化

  摘要：

  在苯乙烯的不对称Rh催化加氢甲酰化反应中，评估了一个由17个模块化且容易获得的酚衍生的手性膦-亚磷酸酯配体的小型文库。发现该反应的立体化学结果高度依赖于手性亚磷酸酯部分和酚骨架上的取代基。在所研究的配体中，在亚磷酸酯邻位带有大取代基的10型基于Taddol的配体表现最佳，对映选择性高达85％ee，区域选择性≥98：2。活性催化剂的高压NMR [HRh（P-P）（CO）2 ]（PP = 10h）揭示了在铑处配体的赤道-顶峰配位。在实验过程中观察到的耦合常数的温度依赖性表明两种赤道-顶峰异构体之间处于平衡状态，其中亚磷酸酯占据赤道位置的异构体占主导地位。

  DOI：

  10.1021/om9009735
• 作为试剂：
  描述：

  L-Leu-Gly-O-t-Bu 、 2-吡咯烷甲醛,1-[(4-甲基苯基)磺酰]-,(2S)- 在 盐酸 、 5A molecular sieve 、 6-溴-2-甲基苯酚 、 sodium cyanoborohydride 作用下， 生成 ((S)-4-Methyl-2-{[(S)-1-(toluene-4-sulfonyl)-pyrrolidin-2-ylmethyl]-amino}-pentanoylamino)-acetic acid tert-butyl ester
  参考文献：
  名称：

  Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agents

  摘要：

  A number of peptides and modified peptides were synthesized and studied for their ability to reverse electroconvulsive shock-induced amnesia in rodents. A few of these peptides were selected for secondary evaluation in tests of short-term memory in rats and aged rhesus monkeys. A number of the peptides and modified peptides were active in the amnesia reversal test. In selected secondary tests, however, the chosen compounds failed to show significant activity in enhancing memory. New methods for preparing methyleneamino and methyleneoxy isosteres of peptides are reported. Other modified peptides also included methylenethio, methylenesulfonyl, and ethylene isosteres in place of the normal peptide amide bond.

  DOI：

  10.1021/jm00156a012

文献信息

• Dual Pharmacophores - PDE4-Muscarinic Antagonistics
  申请人：Callahan James Francis

  公开号：US20090203657A1

  公开（公告）日：2009-08-13

  The present invention is directed to novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions and their use as dual chromaphores having inhibitory activity against PDE4 and muscarinic acetylcholine receptors (mAChRs), and thus being useful for treating respiratory diseases.

  本发明涉及具有式（I）的新化合物及其药用盐，药物组合物及其用作对PDE4和肌胆碱受体（mAChRs）具有抑制活性的双色素，因此可用于治疗呼吸道疾病。
• Transition metal complexes in organic synthesis, part 43. First total synthesis of the free radical scavenger (±)-neocarazostatin B via iron- and nickel-mediated coupling reactions
  作者：Hans-Joachim Knölker、Wolfgang Fröhner、Alfred Wagner

  DOI：10.1016/s0040-4039(98)00527-9

  日期：1998.5

  The first total synthesis of the naturally occurring free radical scavenger (±)-neocarazostatin B is described by using a one-pot iron-mediated construction of the carbazole skeleton and a nickle-mediated prenylation as the key-steps.

  通过使用一锅铁介导的咔唑骨架结构和raz介导的烯丙基化作为关键步骤，描述了自然产生的自由基清除剂（±）-neocarazostatin B的第一个全合成。
• [EN] DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS<br/>[FR] PHARMACOPHORES DUALS, ANTAGONISTES DES RÉCEPTEURS MUSCARINIQUES ET INHIBITEURS DE L'ACTIVITÉ PDE4
  申请人：GLAXO GROUP LTD

  公开号：WO2009100169A1

  公开（公告）日：2009-08-13

  The present invention is directed to novel compounds of Formula's (I) - (VI), and pharmaceutically acceptable salts thereof, pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of and/or prophylaxis of respiratory diseases, including inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis.

  本发明涉及式(I) - (VI)的新化合物，以及其药学上可接受的盐、药物组合物及其在治疗中的应用，例如作为磷酸二酯酶IV (PDE4)的抑制剂和肌碱乙酰胆碱受体 (mAChRs)的拮抗剂，用于治疗和/或预防呼吸道疾病，包括炎症性和/或过敏性疾病，如慢性阻塞性肺病（COPD）、哮喘、鼻炎（例如过敏性鼻炎）、特应性皮炎或银屑病。
• ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY
  申请人：Tamura Yuusuke

  公开号：US20120015961A1

  公开（公告）日：2012-01-19

  The present invention provides, for example, a compound of the following formula (I): wherein R 1 is substituted amino and the like, R 2 is halogen and the like, R 3 is substituted or unsubstituted lower alkyl and the like, R A and R B are each independently hydrogen, substituted or unsubstituted lower alkyl and the like, R C and R D are each independently hydrogen, substituted or unsubstituted lower alkyl, or R C and R D together with the carbon atom to which they are attached may form a substituted or unsubstituted carbocycle, and ring A is a carbocycle or a heterocycle, its pharmaceutically acceptable salt, or a solvate thereof as a therapeutic agent for diseases induced by production, secretion and/or deposition of amyloid-βproteins.

  本发明提供了以下式（I）的化合物，例如： 其中R 1 是取代氨基等， R 2 是卤素等， R 3 是取代或未取代的较低烷基等， R A 和R B 各自独立地是氢、取代或未取代的较低烷基等， R C 和R D 各自独立地是氢、取代或未取代的较低烷基，或R C 和R D 与它们连接的碳原子一起可以形成取代或未取代的碳环，以及 环A是碳环或杂环， 其药学上可接受的盐，或其溶剂合物作为由淀粉样蛋白β的产生、分泌和/或沉积引起的疾病的治疗剂。
• 吡啶类N-氧化衍生物及其制备方法和应用
  申请人：上海翰森生物医药科技有限公司

  公开号：CN110041253B

  公开（公告）日：2022-03-29

  本发明涉及吡啶类N‑氧化衍生物及其制备方法和应用。特别地，本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物，及其作为BRD4抑制剂在治疗癌症、炎症、慢性肝病、糖尿病、心血管疾病和AIDS等相关疾病的用途，其中通式(I)中的各取代基与说明书中的定义相同。